3 ASX Healthcare shares feeling a little under the weather

These 3 ASX healthcare shares have been out-of-form over the past month. We take a look at what could be weighing them down.
The post 3 ASX Healthcare shares feeling a little under the weather appeared first on The Motley Fool Australia. –

healthcare shares

Despite the healthcare leading the gains in the S&P/ASX 200 Index (ASX: XJO) yesterday, there are some healthcare shares that have been out-of-form over the last month.

It can sometimes be useful to take a look at which shares are bucking a sector-wide trend. This can assist in pinpointing which are valuable opportunities and which could be underperformers.

In saying that, let’s take a look at 3 ASX healthcare shares that have been sluggish over the past 30 days.

ASX healthcare shares feeling off

Pro Medicus Ltd (ASX: PME)

Shares in the health imaging software provider have now been following a downward trend for nearly a month. Following the announcement of several new contract signings for its software, the company released its 2021 half-year results.

The company’s results were reasonable with growth across all metrics. However, the market might be apprehensive to buy at these prices due to the founders selling down their holdings following the release. Both Dr. Sam Hupert and Mr. Anthony Hall sold 1 million shares each. This represented 4% of their respective shareholdings.

The Pro Medicus share price has fallen 6.3% in the last month. Whereas the company’s shares have appreciated by 62% in the past 6 months.

Volpara Health Technologies (ASX: VHT)

The Volpara Health share price has been under pressure since February. The New Zealand-based healthcare software provider of breast imaging services has fallen nearly 15% over the last month.

Despite the company’s revenue growth and expansion through acquisition, this ASX healthcare share has continued to sell-off. Most recently, Volpara announced the signing of its highest value contract to date. The deal with CRA Health is worth US$400,000 per year in annual recurring revenue (ARR) terms.

It is possible that the market wasn’t overly impressed with the announcement considering CRA Health was acquired by Volpara recently. Hence, the payment from CRA is more so internal money shifting.

Noxopharm Ltd (ASX: NOX)

This ASX healthcare share has certainly seen better days. The Noxopharm share price has dropped by 27% in the past month of trading.

The clinical-stage drug development company has been in a state of decline since it reported half-year results. Being in the early stages of drug development, Noxopharm reported a hefty $6.7 million loss on the bottom line for the half.

Unfortunately for Noxopharm, this result was released around the time when investors began being more cognisant of valuations. As a result, it appears not even news of the company’s Veyonda drug moving to its final stage of the clinical trial has been able to turnaround the market’s sentiment.

On a positive note, the Noxopharm share price has gained 106% in the last 6 months. 

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Mitchell Lawler owns shares of Pro Medicus Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. and VOLPARA FPO NZ. The Motley Fool Australia has recommended Pro Medicus Ltd. and VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 3 ASX Healthcare shares feeling a little under the weather appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!